Showing 1 - 9 results of 9 for search 'M Yu Zubareva', query time: 0.04s
Refine Results
-
1
New hypolipidemic drugs from the group of reductase inhibitors GMG-CoA by A V Susekov, M Yu Zubareva, V V Kukharchuk
Published 2003-02-01
Article -
2
-
3
-
4
-
5
-
6
Randomized «FARVATER» study. Atorvastatin (10 and 20 mg/d) in treating patients with coronary heart disease and dyslipidemia: effects on lipids, C-reactive protein and fibrinogen l... by A. V. Susekov, M. Yu. Zubareva, M. I. Tripoten’, T. A. Rozhkova, O. A. Pogorelova, T. V. Balakhonova, V. P. Masenko, V. V. Kukharchuk
Published 2006-12-01
Article -
7
ANICHKOV study: the effect of combined hypotensive and lipid-lowering therapy on cardiovascular complications in patients of high and very high risk by I V Sergienko, A A Ansheles, O M Drapkina, N B Gornyakova, M Yu Zubareva, R N Shepel, V V Kuharchuk, S A Boytsov
Published 2019-04-01
Article -
8
ASSESSMENT OF THE EFFECT OF RS2230806 ALLELIC VARIANT IN THE ABCA1 GENE ON THE LIPID-LOWERING EFFECTS OF ATORVASTATIN IN PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA by G. P. Smirnov, T. A. Rozhkova, M. Yu. Zubareva, Yu. A. Shuvalova, D. V. Rebrikov, A. I. Kaminny, V. N. Titov, V. V. Kukharchuk, P. P. Malyshev
Published 2018-09-01
Article -
9
Randomized study FARVATER: Part II. Atorvastatin effects on endothelial function, vascular wall distensibility and stiffness by A. V. Susekov, T. A. Rozhkova, M. I. Tripoten’, O. A. Pogorelova, B. D. Kulev, T. V. Balakhonova, M. Yu. Zubareva, V. P. Masenko, A. N. Rogoza, V. V. Kukharchuk
Published 2007-06-01
Article